Showing results (441-450 of 1,523) with videos related to
Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|February 23, 2018
Development, Verification, and Prediction of Osimertinib Drug-Drug Interactions Using PBPK Modeling Approach to Inform Drug LabelVenkatesh Pilla Reddy, Michael Walker, Pradeep Sharma, et al.CPT: Pharmacometrics & Systems Pharmacology|March 2, 2018
Modeling Composite Assessment Data Using Item Response TheorySebastian UeckertCPT: Pharmacometrics & Systems Pharmacology|January 20, 2023
Bayesian PBPK modeling using R/Stan/Torsten and Julia/SciML/Turing.JlAhmed Elmokadem, Yi Zhang, Timothy Knab, et al.CPT: Pharmacometrics & Systems Pharmacology|July 28, 2021
ModVizPop: A shiny interface for empowering teams to perform interactive pharmacokinetic/pharmacodynamic simulationsPavan Vaddady, Bhargava KandalaCPT: Pharmacometrics & Systems Pharmacology|July 27, 2021
Multistate model for pharmacometric analyses of overall survival in HER2-negative breast cancer patients treated with docetaxelSreenath M Krishnan, Lena E Friberg, René Bruno, et al.CPT: Pharmacometrics & Systems Pharmacology|November 10, 2018
Open Source Pharmacokinetic/Pharmacodynamic Framework: Tutorial on the BioGears EngineMatthew McDaniel, Jennifer Carter, Jonathan M Keller, et al.CPT: Pharmacometrics & Systems Pharmacology|November 19, 2016
Building confidence in quantitative systems pharmacology models: An engineer's guide to exploring the rationale in model design and developmentJ Timmis, K Alden, P Andrews, et al.CPT: Pharmacometrics & Systems Pharmacology|November 19, 2016
Modeling Longitudinal Preclinical Tumor Size Data to Identify Transient Dynamics in Tumor Response to Antiangiogenic DrugsL G Hutchinson, H-J Mueller, E A Gaffney, et al.CPT: Pharmacometrics & Systems Pharmacology|October 26, 2016
Exploratory Population PK Analysis of Dupilumab, a Fully Human Monoclonal Antibody Against IL-4Rα, in Atopic Dermatitis Patients and Normal VolunteersP Kovalenko, A T DiCioccio, J D Davis, et al.CPT: Pharmacometrics & Systems Pharmacology|January 31, 2014
Incorporating Target Shedding Into a Minimal PBPK-TMDD Model for Monoclonal AntibodiesL Li, I Gardner, R Rose, et al.Pageof 153